Literature DB >> 16817017

Induction of human UDP-glucuronosyltransferase 1A1 by cortisol-GR.

Toru Usui1, Takuya Kuno, Takaharu Mizutani.   

Abstract

During the course of the study of UGT1A1 induction by bilirubin, we could not detect the induction of the reporter gene (-3174/+14) of human UGT1A1 in HepG2 by bilirubin (Mol. Biol. Rep. 31: 151-158 (2004)). In this report, we show the finding of the induction of the reporter gene of UGT1A1 by cortisol at 1 microM, a major natural cortico-steroid, with human glucocorticoid receptor (GR). RU486 of a typical GR antagonist at 10 microM inhibited the induction by cortisol from 5.9- to 1.8-fold. This result indicates that the induction by cortisol-GR is dependence on ligand-binding. This induction is caused by the UGT reporter gene itself, from the results of noinduction with control vector pGL2 (equal to pGV-C) in the presence of cortisol-GR. We confirmed that the induction of the reporter gene by cortisol is dependent on the position of proximal element (-97/-53) of UGT1A1. From this result, we concluded that the increase of corticosteroid in neonates must induce the elevation of UGT1A1 after birth and prevent jaundice. With the study of induction by corisol, we studied the influence of co-expression of PXR (pregnenolone xenobiotic receptor) with the UGT1A1 reporter gene and we could not find the induction of UGT1A1 expression in the presence of dexamethasone, rifampicin, or pregnenolone 16alpha-carbonitrile of the PXR ligands. These results suggest that the induction of UGT1A1 expression by GR is not mediated by PXR, unlike the induction of CYP3A4 through PXR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16817017     DOI: 10.1007/s11033-005-1750-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus.

Authors:  Q H Gong; J W Cho; T Huang; C Potter; N Gholami; N K Basu; S Kubota; S Carvalho; M W Pennington; I S Owens; N C Popescu
Journal:  Pharmacogenetics       Date:  2001-06

2.  The glucuronidation of morphine by dog liver microsomes: identification of morphine-6-O-glucuronide.

Authors:  C King; B Finley; R Franklin
Journal:  Drug Metab Dispos       Date:  2000-06       Impact factor: 3.922

3.  Functional domains of the human estrogen receptor.

Authors:  V Kumar; S Green; G Stack; M Berry; J R Jin; P Chambon
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

Review 4.  Developmental aspects of drug conjugation, with special reference to glucuronidation.

Authors:  G J Dutton
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

5.  Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1.

Authors:  P Bernard; H Goudonnet; Y Artur; B Desvergne; W Wahli
Journal:  Mol Pharmacol       Date:  1999-09       Impact factor: 4.436

6.  Induction of bilirubin clearance by the constitutive androstane receptor (CAR).

Authors:  Wendong Huang; Jun Zhang; Steven S Chua; Mohammed Qatanani; Yunqing Han; Riccarda Granata; David D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

7.  Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.

Authors:  Wen Xie; Mei-Fei Yeuh; Anna Radominska-Pandya; Simrat P S Saini; Yoichi Negishi; Bobbie Sue Bottroff; Geraldine Y Cabrera; Robert H Tukey; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

8.  The activity of the highly inducible mouse phenylalanine hydroxylase gene promoter is dependent upon a tissue-specific, hormone-inducible enhancer.

Authors:  D M Faust; A M Catherin; S Barbaux; L Belkadi; T Imaizumi-Scherrer; M C Weiss
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome.

Authors:  M Pontoglio; J Barra; M Hadchouel; A Doyen; C Kress; J P Bach; C Babinet; M Yaniv
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

10.  Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.

Authors:  G Monaghan; M Ryan; R Seddon; R Hume; B Burchell
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

View more
  11 in total

1.  Effect of Pregnancy on Unbound Raltegravir Concentrations in the ANRS 160 RalFe Trial.

Authors:  Yi Zheng; Déborah Hirt; Sandrine Delmas; Gabrielle Lui; Sihem Benaboud; Jerome Lechedanec; Jean-Marc Tréluyer; Camille Chenevier-Gobeaux; Elisa Arezes; Ambre Gelley; Imane Amri; Saïk Urien; Naïm Bouazza; Frantz Foissac; Josiane Warszawski; Jade Ghosn
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Induction of the UDP-Glucuronosyltransferase 1A1 during the Perinatal Period Can Cause Neurodevelopmental Toxicity.

Authors:  Rika Hirashima; Hirofumi Michimae; Hiroaki Takemoto; Aya Sasaki; Yoshinori Kobayashi; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Mol Pharmacol       Date:  2016-07-13       Impact factor: 4.436

Review 3.  The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease.

Authors:  Catherine M T Sherwin; Tsuyoshi Fukuda; Hermine I Brunner; Jens Goebel; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2011-01       Impact factor: 6.447

Review 4.  Interactions between nuclear receptors glucocorticoid receptor α and peroxisome proliferator-activated receptor α form a negative feedback loop.

Authors:  Hongjiao Gao; Yujue Li; Xiang Chen
Journal:  Rev Endocr Metab Disord       Date:  2022-04-27       Impact factor: 9.306

5.  Population Pharmacokinetics of Mycophenolic Acid Co-Administered with Tacrolimus in Corticosteroid-Free Adult Kidney Transplant Patients.

Authors:  Yan Rong; Patrick Mayo; Mary H H Ensom; Tony K L Kiang
Journal:  Clin Pharmacokinet       Date:  2019-11       Impact factor: 6.447

6.  Induction of human UGT1A1 by a complex of dexamethasone-GR dependent on proximal site and independent of PBREM.

Authors:  Takuya Kuno; Hiroshi Togawa; Takaharu Mizutani
Journal:  Mol Biol Rep       Date:  2007-05-26       Impact factor: 2.316

7.  Genetic polymorphisms in the TATA box and upstream phenobarbital-responsive enhancer module of the UGT1A1 promoter have combined effects on UDP-glucuronosyltransferase 1A1 transcription mediated by constitutive androstane receptor, pregnane X receptor, or glucocorticoid receptor in human liver.

Authors:  Ye Li; David Buckley; Shuang Wang; Curtis D Klaassen; Xiao-bo Zhong
Journal:  Drug Metab Dispos       Date:  2009-06-18       Impact factor: 3.922

8.  Toxicity of xanthene food dyes by inhibition of human drug-metabolizing enzymes in a noncompetitive manner.

Authors:  Takaharu Mizutani
Journal:  J Environ Public Health       Date:  2009-08-23

9.  Glucose induces intestinal human UDP-glucuronosyltransferase (UGT) 1A1 to prevent neonatal hyperbilirubinemia.

Authors:  Naoya Aoshima; Yoshiko Fujie; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Sci Rep       Date:  2014-09-11       Impact factor: 4.379

10.  Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCT.

Authors:  Jorien Werumeus Buning; Jenny E Kootstra-Ros; Pauline Brummelman; Gerrit van den Berg; Melanie van der Klauw; Bruce H R Wolffenbuttel; André P van Beek; Robin P F Dullaart
Journal:  Eur J Clin Invest       Date:  2016-04-15       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.